Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Astrocytoma × Interleukin-2 × Clear all

Sponsor

Conditions

Melanoma 38 Neoplasm Metastasis 16 Leukemia, Myeloid, Acute 13 Skin Neoplasms 10 Kidney Neoplasms 10 Leukemia 9 Carcinoma, Renal Cell 9 Neoplasms 7 Ovarian Neoplasms 6 Breast Neoplasms 6 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Congenital Abnormalities 4 Neuroblastoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Recurrence 2 Papillomavirus Infections 2 Lymphoma, Mantle-Cell 2 Hodgkin Disease 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1

Interventions

Temozolomide 29 Bevacizumab 15 Radiotherapy 13 antineoplaston AS 2-1 8 antineoplaston A10 8 Everolimus 7 Radiation 6 Erlotinib Hydrochloride 6 Radiotherapy, Intensity-Modulated 5 Lomustine 4 veliparib 3 palbociclib 3 Vorinostat 3 Sunitinib 3 Radiotherapy, Conformal 3 Magnetic Resonance Spectroscopy 3 Carmustine 3 Carboplatin 3 temsirolimus 2 selinexor 2 poly ICLC 2 etoposide phosphate 2 cabozantinib 2 Sirolimus 2 Nivolumab 2 Irinotecan 2 Immunoglobulin G 2 Imatinib Mesylate 2 Etoposide 2 Donepezil 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡